MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Bayer Company News' source. Thu, 09 Feb 2012 01:31:28 +0100 http://www.medworm.com/index.php?rid=5651487&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fbaynews.bayer.de%2Fbaynews%2Fbaynews.nsf%2Fid%2FC655448F20C14459C125799800334865%2F%24file%2F2012-0060-T.jpg Pilot plant in Leverkusen is one of the “Selected Landmarks 2012” / Innovative process for producing plastics with carbon dioxide (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5651487 Thu, 02 Feb 2012 10:20:00 +0100 5651487 http://www.medworm.com/index.php?rid=5639966&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fbaynews.bayer.de%2Fbaynews%2Fbaynews.nsf%2Fid%2FD6DCFE5A7F699837C125799200317FF4%2F%24file%2F2012-0036-T.jpg (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5639966 Fri, 27 Jan 2012 13:00:00 +0100 5639966 http://www.medworm.com/index.php?rid=5639967&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com One of just three chemical companies worldwide to receive Gold Class seal of quality from rating agency SAM (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5639967 Fri, 27 Jan 2012 12:00:00 +0100 5639967 http://www.medworm.com/index.php?rid=5612222&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fbaynews.bayer.de%2Fbaynews%2Fbaynews.nsf%2Fid%2FCAE2A31342B57055C125798B002AC43B%2F%24file%2F2012-0014-T.jpg Total investment of roughly EUR 35 million / Efficient and flexible production of HDI and IPDI / Rising demand for high-performance polyurethane automotive coatings (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5612222 Fri, 20 Jan 2012 13:30:00 +0100 5612222 http://www.medworm.com/index.php?rid=5612223&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5612223 Wed, 18 Jan 2012 07:00:00 +0100 5612223 http://www.medworm.com/index.php?rid=5600113&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com First presentation of data from CORRECT trial as “Late Breaking Abstract” at the 2012 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI) (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5600113 Tue, 17 Jan 2012 23:00:00 +0100 5600113 http://www.medworm.com/index.php?rid=5553980&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5553980 Thu, 29 Dec 2011 13:00:00 +0100 5553980 http://www.medworm.com/index.php?rid=5527881&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Submission based on positive results of ATLAS ACS 2-TIMI 51 study / Xarelto is the only new oral anticoagulant to demonstrate significant clinical benefit in this indication when used in combination with standard antiplatelet therapy (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5527881 Thu, 22 Dec 2011 10:15:00 +0100 5527881 http://www.medworm.com/index.php?rid=5527882&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Good prospects for Xarelto™, VEGF Trap-Eye, Alpharadin and regorafenib / Market launches in the next 18 months planned / Research and development budget for 2012 approximately EUR 3 billion again (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5527882 Tue, 20 Dec 2011 11:00:00 +0100 5527882 http://www.medworm.com/index.php?rid=5516855&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com In stroke prevention in AF, Xarelto is the only oral anticoagulant offering patients a once-daily, highly effective therapy without need for routine coagulation monitoring / For the treatment of DVT and the prevention of recurrent DVT and PE, Xarelto is the first oral anticoagulant to offer patients both efficacy and the convenience of a single-drug solution, without the need for injections or monitoring / Xarelto is now approved in the EU across three indications in the area of venous and arterial thromboembolism (VAT) (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5516855 Mon, 19 Dec 2011 13:10:00 +0100 5516855 http://www.medworm.com/index.php?rid=5516856&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Home for orphans in Tohoku region / Bayer’s relief aid to Japan totals almost EUR 2.3 million (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5516856 Mon, 19 Dec 2011 10:00:00 +0100 5516856 http://www.medworm.com/index.php?rid=5516857&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fbaynews.bayer.de%2Fbaynews%2Fbaynews.nsf%2Fid%2FA5C21E0CCA8A56D9C125796800552367%2F%24file%2FCristobal-Uauy-T.jpg Dr. Cristobal Uauy (John Innes Centre in Norwich, Great Britain) wins the „Biology“ category / Dr. Andreas Bender (University of Cambridge, Great Britain) takes the „Chemistry“ award / Prof. Dr. Arne Thomas (Technical University Berlin) awarded prize in the „Materials“ field (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5516857 Mon, 19 Dec 2011 09:00:00 +0100 5516857 http://www.medworm.com/index.php?rid=5507515&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5507515 Thu, 15 Dec 2011 17:36:00 +0100 5507515 http://www.medworm.com/index.php?rid=5507516&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Once approved, the new low dose IUS will offer young women contraception for up to three years (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5507516 Wed, 14 Dec 2011 07:30:00 +0100 5507516 http://www.medworm.com/index.php?rid=5489158&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5489158 Fri, 09 Dec 2011 01:40:00 +0100 5489158 http://www.medworm.com/index.php?rid=5478959&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Patients receiving VEGF Trap-Eye 2mg every other month achieved visual acuity gains similar to ranibizumab with, on average, five fewer injections over two years / Patients who required the most intense therapy, on average, received 1.4 fewer injections in the VEGF Trap-Eye 2mg every other month group compared to the ranibizumab group in the second year (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5478959 Mon, 05 Dec 2011 07:30:00 +0100 5478959 http://www.medworm.com/index.php?rid=5451071&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5451071 Mon, 28 Nov 2011 07:30:00 +0100 5451071 http://www.medworm.com/index.php?rid=5433669&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fbaynews.bayer.de%2Fbaynews%2Fbaynews.nsf%2Fid%2F783CA66202E9EE38C12579500047D074%2F%24file%2F2011-0598-T.jpg (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5433669 Tue, 22 Nov 2011 14:45:00 +0100 5433669 http://www.medworm.com/index.php?rid=5411864&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Personalized medicine against cancer / Creating new active crop protection ingredients with biotechnology / Electric mobility: materials for the cars of the future (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5411864 Thu, 17 Nov 2011 09:00:00 +0100 5411864 http://www.medworm.com/index.php?rid=5411865&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fbaynews.bayer.de%2Fbaynews%2Fbaynews.nsf%2Fid%2F7DCCF45A8054215DC125794900433D30%2F%24file%2F2011-0583-1-T.jpg Sales in the region to grow to well over EUR 11 billion by 2015 / Some EUR 6 billion in sales expected in Greater China alone / Plans to expand production, distribution network and research / Further capital expenditures of EUR 1.8 billion in Asia by 2015 / New TDI production facility dedicated in Shanghai (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5411865 Wed, 16 Nov 2011 05:29:00 +0100 5411865 http://www.medworm.com/index.php?rid=5402236&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Rivaroxaban Meets Primary Efficacy Endpoint, Significantly Reducing the Composite of Cardiovascular Death, Myocardial Infarction and Stroke / Rivaroxaban 2.5 mg twice daily Significantly Reduced Both the Rate of Cardiovascular Death and the Incidence of All-Cause Mortality by more than 30% / Major Bleeding in Patients Receiving Rivaroxaban was Significantly Increased but there was no Increase in the Risk of Fatal Bleeding / Study Results Presented as a Late-Breaker at the Scientific Sessions of the American Heart Association and Published by the New England Journal of Medicine (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5402236 Sun, 13 Nov 2011 13:00:00 +0100 5402236 http://www.medworm.com/index.php?rid=5391351&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Rivaroxaban is highly effective and well tolerated in protecting patients with Atrial Fibrillation from stroke / Rivaroxaban is the only anticoagulant with once-daily fixed dosing for stroke prevention in patients with atrial fibrillation / Rivaroxaban does not require routine coagulation monitoring, making it more convenient to both patients and physicians (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5391351 Fri, 04 Nov 2011 19:00:00 +0100 5391351 http://www.medworm.com/index.php?rid=5350634&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Sales up by 4.8 percent (adjusted) to EUR 8,670 million / Continuing growth momentum in the emerging markets (adjusted: plus 9.5 percent) / Operating result (EBIT) increased by 94.9 percent to EUR 1,099 million / EBITDA before special items up by 8.5 percent to EUR 1,805 million / HealthCare and CropScience margins distinctly improved – MaterialScience weaker / Net income more than doubled to EUR 642 million (plus 125.3 percent) (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5350634 Thu, 27 Oct 2011 05:30:00 +0100 5350634 http://www.medworm.com/index.php?rid=5350635&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Trial stopped based on positive data from a pre-planned interim analysis (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5350635 Wed, 26 Oct 2011 06:30:00 +0100 5350635 http://www.medworm.com/index.php?rid=5326152&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fbaynews.bayer.de%2Fbaynews%2Fbaynews.nsf%2Fid%2FFC0904272E8C35CCC125792C003295F3%2F%24file%2F2011-0551-1T.jpg Around 50 young people from Africa, Asia and Latin America participate in a week-long study trip on the environment / The program is part of the partnership between Bayer and the United Nations Environment Programme (UNEP) (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5326152 Mon, 17 Oct 2011 12:00:00 +0100 5326152 http://www.medworm.com/index.php?rid=5298660&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fbaynews.bayer.de%2Fbaynews%2Fbaynews.nsf%2Fid%2F9A90FF2B7D989420C1257921004242D9%2F%24file%2F2011-0367-1-T.jpg Accelerated entry into the European oilseed rape market (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5298660 Fri, 07 Oct 2011 12:00:00 +0100 5298660 http://www.medworm.com/index.php?rid=5288351&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Positive development despite earthquake and tsunami / Sales to grow by an average 6 percent annually through 2015 / Donation of EUR 700,000 for long-term reconstruction project in the earthquake zone / Bayer's relief aid totals nearly EUR 2.3 million (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5288351 Wed, 05 Oct 2011 07:15:00 +0100 5288351 http://www.medworm.com/index.php?rid=5253333&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com First presentation of full data as part of Presidential Session featuring best and late-breaking abstracts at 2011 European Multidisciplinary Cancer Congress (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5253333 Fri, 23 Sep 2011 22:01:00 +0100 5253333 http://www.medworm.com/index.php?rid=5253334&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com CHMP recommends approval of rivaroxaban for two new chronic indications / Upon approval, rivaroxaban would be the only new oral anticoagulant approved in three indications in all EU member states / Decision of European Commisson on approval expected in fourth quarter 2011 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5253334 Fri, 23 Sep 2011 13:00:00 +0100 5253334 http://www.medworm.com/index.php?rid=5228960&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fbaynews.bayer.de%2Fbaynews%2Fbaynews.nsf%2Fid%2F7C38B7DA40D9FA7AC125790B00736CEB%2F%24file%2F2011-0483-T.jpg Investment in BioScience research to double by 2015 / Accelerated portfolio conversion: Phase-out of WHO Class I products by end of 2012 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5228960 Thu, 15 Sep 2011 08:31:00 +0100 5228960 http://www.medworm.com/index.php?rid=5228961&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Recognition of transparent reporting and contributions to reducing CO2 / Indices offer guidance for sustainable investment (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5228961 Wed, 14 Sep 2011 14:15:00 +0100 5228961 http://www.medworm.com/index.php?rid=5212854&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5212854 Thu, 08 Sep 2011 22:20:00 +0100 5212854 http://www.medworm.com/index.php?rid=5198631&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5198631 Tue, 06 Sep 2011 14:00:00 +0100 5198631 http://www.medworm.com/index.php?rid=5186634&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Transaction complements business portfolio in vascular intervention technologies (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5186634 Thu, 01 Sep 2011 06:30:00 +0100 5186634 http://www.medworm.com/index.php?rid=5149410&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5149410 Tue, 23 Aug 2011 06:00:00 +0100 5149410 http://www.medworm.com/index.php?rid=5149411&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fbaynews.bayer.de%2Fbaynews%2Fbaynews.nsf%2Fid%2FA2364DACBE646ED4C12578F1003EDFEC%2F%24file%2F2011-0424-1T.jpg (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5149411 Fri, 19 Aug 2011 17:00:00 +0100 5149411 http://www.medworm.com/index.php?rid=5112494&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com EUR 100,000 donated to the U.N. World Food Programme (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5112494 Mon, 08 Aug 2011 08:00:00 +0100 5112494 http://www.medworm.com/index.php?rid=5072631&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Sales up 5.4 percent on an adjusted basis to EUR 9,252 million / Operating result (EBIT) advances 25.9 percent to EUR 1,273 million / EBITDA before special items increases by 5.8 percent to EUR 2,035 million / Net income rises by substantial 40.9 percent to EUR 747 million / Group outlook for 2011 confirmed / Significant progress with innovation projects / Efficiency measures advancing well (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5072631 Thu, 28 Jul 2011 05:30:00 +0100 5072631 http://www.medworm.com/index.php?rid=5058973&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Safety of once-daily Xarelto comparable to warfarin in Japanese patients with atrial fibrillation / Results presented in the late breaking clinical trials session at the 23rd Congress of the International Society on Thrombosis and Haemostasis in Kyoto, Japan / As communicated in April 2011, Xarelto has been submitted for marketing approval in the prevention of stroke in patients with atrial fibrillation to the Japanese Ministry of Health, Labor and Welfare (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5058973 Sun, 24 Jul 2011 23:15:00 +0100 5058973 http://www.medworm.com/index.php?rid=5032380&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5032380 Fri, 01 Jul 2011 22:05:00 +0100 5032380 http://www.medworm.com/index.php?rid=5032381&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Xarelto® is the only new oral anticoagulant with US approval in this indication (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=5032381 Fri, 01 Jul 2011 17:30:00 +0100 5032381 http://www.medworm.com/index.php?rid=4906850&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4906850 Tue, 07 Jun 2011 06:30:00 +0100 4906850 http://www.medworm.com/index.php?rid=4897600&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Trial Stopped Based on Positive Data from Pre-Planned Interim Analysis / Patients on Placebo Arm will be Offered Treatment with Alpharadin (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4897600 Mon, 06 Jun 2011 05:00:00 +0100 4897600 http://www.medworm.com/index.php?rid=4835131&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fbaynews.bayer.de%2Fbaynews%2Fbaynews.nsf%2Fid%2F03645FFA350885ACC12578930024F776%2F%24file%2F2011-0258-T.Jpg New climate target – reduction in specific greenhouse gas emissions by 35 percent / Health care – contraceptives made available to 16 million women in developing countries / Nutrition – 240 partnership projects implemented for sustainable food / Bayer stock included in sustainability indices / EUR 57 million for charitable causes (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4835131 Tue, 17 May 2011 08:00:00 +0100 4835131 http://www.medworm.com/index.php?rid=4772747&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Increase of annual capacity of plant in Germany to 400,000 tons / EUR 90 million investment in stepped expansion at Uerdingen plant (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4772747 Mon, 02 May 2011 12:00:00 +0100 4772747 http://www.medworm.com/index.php?rid=4772748&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fbaynews.bayer.de%2Fbaynews%2Fbaynews.nsf%2Fid%2F115300AD7195F72EC125788000699D50%2F%24file%2F2011-0212-1-T.Jpg Group targets achieved in 2010 / Proposal to raise dividend for 2010 to EUR 1.50 per share / Successful start to 2011 with sales and earnings gains in all subgroups / Investment for the future planned to total EUR 15 billion through 2013 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4772748 Fri, 29 Apr 2011 08:00:00 +0100 4772748 http://www.medworm.com/index.php?rid=4760156&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Sales up by 13.2 percent to EUR 9,415 million / Operating result (EBIT) rises by 4.0 percent to EUR 1,148 million / EBITDA before special items advances by 22.3 percent to EUR 2,232 million / Special items of EUR 442 million diminish earnings / Net income up 8.4 percent to EUR 684 million / Group forecast raised – improvement expected at CropScience (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4760156 Thu, 28 Apr 2011 05:30:00 +0100 4760156 http://www.medworm.com/index.php?rid=4755928&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Phase 3 GALILEO study confirms results of previously announced Phase 3 COPERNICUS study (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4755928 Wed, 27 Apr 2011 20:05:00 +0100 4755928 http://www.medworm.com/index.php?rid=4711539&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4711539 Thu, 14 Apr 2011 02:00:00 +0100 4711539 http://www.medworm.com/index.php?rid=4688941&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4688941 Fri, 08 Apr 2011 08:00:00 +0100 4688941 http://www.medworm.com/index.php?rid=4688942&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Extends ophthalmology research & development program for VEGF Trap-Eye (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4688942 Fri, 08 Apr 2011 06:30:00 +0100 4688942 http://www.medworm.com/index.php?rid=4678828&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com MAGELLAN study meets primary efficacy endpoints of demonstrating non-inferiority in short-term use and superiority in long-term use / Primary analysis shows no consistent positive benefit-risk balance across heterogeneous patient population studied (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4678828 Tue, 05 Apr 2011 13:00:00 +0100 4678828 http://www.medworm.com/index.php?rid=4672954&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.presse.bayer.de%2Fbaynews%2Fbaynews.nsf%2F4a6223d2b5e7ed5bc12571f400362eb9%2F54586095ab36a200c1257865004f26ed%2Fb0%2F0.84%3FOpenElement%26amp%3BFieldElemFormat%3Djpg (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4672954 Mon, 04 Apr 2011 07:30:00 +0100 4672954 http://www.medworm.com/index.php?rid=4628633&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com FTSE4Good and ASPI listings confirmed (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4628633 Thu, 24 Mar 2011 14:50:00 +0100 4628633 http://www.medworm.com/index.php?rid=4628634&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4628634 Wed, 23 Mar 2011 13:00:00 +0100 4628634 http://www.medworm.com/index.php?rid=4585356&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Immediate Relief and Sustainable Support Worth More Than EUR 1 Million (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4585356 Tue, 15 Mar 2011 12:10:00 +0100 4585356 http://www.medworm.com/index.php?rid=4585357&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com MDI plant Brunsbüttel: rise of production capacity to 420,000 metric tons a year (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4585357 Mon, 14 Mar 2011 10:00:00 +0100 4585357 http://www.medworm.com/index.php?rid=4537741&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Facility closed significantly oversubscribed (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4537741 Wed, 02 Mar 2011 16:10:00 +0100 4537741 http://www.medworm.com/index.php?rid=4534131&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com The Company donates Cash and Products of more than EUR 170,000 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4534131 Tue, 01 Mar 2011 11:00:00 +0100 4534131 http://www.medworm.com/index.php?rid=4534132&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.presse.bayer.de%2Fbaynews%2Fbaynews.nsf%2F4a6223d2b5e7ed5bc12571f400362eb9%2F6395f8efa2e7155ec12578430041b2b2%2Fb0%2F0.84%3FOpenElement%26FieldElemFormat%3Djpg Group targets achieved / Strong year at MaterialScience – HealthCare and CropScience below expectations / Net income diminished by high special charges / Strong operating cash flow – net financial debt below EUR 8 billion / Confidence for 2011: core earnings per share expected to improve by about 10 percent / About EUR 15 billion investment for the future planned through 2013 / Proportion of female managers to grow toward 30 percent by 2015 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4534132 Mon, 28 Feb 2011 06:31:00 +0100 4534132 http://www.medworm.com/index.php?rid=4514545&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4514545 Thu, 24 Feb 2011 16:00:00 +0100 4514545 http://www.medworm.com/index.php?rid=4519243&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.presse.bayer.de%2Fbaynews%2Fbaynews.nsf%2F4a6223d2b5e7ed5bc12571f400362eb9%2Ff7d95a62e946f894c125783a002f2cb5%2Fb0%2F0.84%3FOpenElement%26amp%3BFieldElemFormat%3Djpg High-ranking representatives attend the initiation ceremony in Leverkusen (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4519243 Thu, 17 Feb 2011 09:30:00 +0100 4519243 http://www.medworm.com/index.php?rid=4434279&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4434279 Fri, 04 Feb 2011 07:30:00 +0100 4434279 http://www.medworm.com/index.php?rid=4416229&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Streamlining administration, strengthening research and development / Handover in management of Consumer Care Division / Site consolidation at the U.S. East Coast (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4416229 Mon, 31 Jan 2011 15:00:00 +0100 4416229 http://www.medworm.com/index.php?rid=4408203&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com UN Secretary-General Ban Ki-moon: Business leaders willing to move beyond status quo are key for sustainability / Bayer Board of Management Chairman Dr. Dekkers: We play an active role in the important UN initiative (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4408203 Fri, 28 Jan 2011 12:00:00 +0100 4408203 http://www.medworm.com/index.php?rid=4408204&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4408204 Fri, 28 Jan 2011 07:20:00 +0100 4408204 http://www.medworm.com/index.php?rid=4379592&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Energy consumption around 50 percent of comparable buildings / Bayer Board of Management member Dr. Plischke: Linking innovation and sustainability (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4379592 Fri, 21 Jan 2011 12:00:00 +0100 4379592 http://www.medworm.com/index.php?rid=4357770&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com The Company donates Cash and Products of more than EUR 85,000 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4357770 Tue, 18 Jan 2011 15:45:00 +0100 4357770 http://www.medworm.com/index.php?rid=4357771&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Collaboration with the Singapore Eye Research Institute to tackle a major eye disease common in Asia (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4357771 Tue, 18 Jan 2011 07:00:00 +0100 4357771 http://www.medworm.com/index.php?rid=4328219&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4328219 Mon, 10 Jan 2011 13:00:00 +0100 4328219 http://www.medworm.com/index.php?rid=4328220&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Bayer’s dermatology unit Intendis one step closer to enter aesthetics segment / Joint development of first-in-class injectable drug for minimally invasive facial fat reduction (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4328220 Mon, 10 Jan 2011 11:00:00 +0100 4328220 http://www.medworm.com/index.php?rid=4311234&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Submission in Stroke Prevention in Patients with Atrial Fibrillation (AF) based on positive results of ROCKET AF trial in more than 14,000 patients / Submission in Treatment of DVT and Prevention of Recurrent DVT and PE based on positive results of EINSTEIN-DVT and EINSTEIN-Extension clinical studies in more than 4,500 patients (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4311234 Wed, 05 Jan 2011 09:15:00 +0100 4311234 http://www.medworm.com/index.php?rid=4279327&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com New treatments in the battle against cancer / Biotechnology for more robust, higher-yielding plants / Organic light-emitting diodes for more energy-efficient light (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4279327 Wed, 22 Dec 2010 12:15:00 +0100 4279327 http://www.medworm.com/index.php?rid=4273835&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com In Phase 3 study in CRVO, 56 percent of VEGF Trap-Eye patients gained at least 15 letters of vision compared to 12 percent in control group / In Phase 2 study in DME, patients in all VEGF Trap-Eye dose groups, including VEGF Trap-Eye dosed every two months, maintained or increased vision gains through 52-weeks (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4273835 Mon, 20 Dec 2010 11:15:00 +0100 4273835 http://www.medworm.com/index.php?rid=4255749&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4255749 Mon, 13 Dec 2010 15:00:00 +0100 4255749 http://www.medworm.com/index.php?rid=4255750&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Focus on yield, drought tolerance and fertilizer use efficiency / Use of both advanced breeding and genetic modification methods (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4255750 Mon, 13 Dec 2010 07:30:00 +0100 4255750 http://www.medworm.com/index.php?rid=4247497&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Will support women in managing their menstrual cycle individually / Minimizes the number of bleedings / Innovative device, supporting women to follow an individualized intake regimen (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4247497 Fri, 10 Dec 2010 07:30:00 +0100 4247497 http://www.medworm.com/index.php?rid=4243529&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Group sales in Greater China planned to increase to around EUR 5 billion by 2015 / New MaterialScience production plants to be constructed and existing ones expanded /Expansion of research and development activities / Headquarters of the Polycarbonates Business Unit to move to Shanghai (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4243529 Thu, 09 Dec 2010 01:30:00 +0100 4243529 http://www.medworm.com/index.php?rid=4239834&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com 2010: planned expenditures of EUR 3.1 billion for research and development / Pharmaceutical pipeline well stocked with currently more than 50 projects in all clinical phases / CropScience to introduce six new substances by 2012 and expand BioScience activities / Bayer CEO Dekkers calls for more acceptance of industrial projects and new technologies (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4239834 Wed, 08 Dec 2010 08:59:00 +0100 4239834 http://www.medworm.com/index.php?rid=4210523&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Registration of Large-Volume Chemicals Completed on Time (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4210523 Mon, 29 Nov 2010 10:45:00 +0100 4210523 http://www.medworm.com/index.php?rid=4194031&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Dr. Oliver Daumke (Max Delbrück Center for Molecular Medicine in Berlin) wins in the “Biology” category / Prof. Nicolai Cramer (École polytechnique fédérale de Lausanne, Switzerland) takes the “Chemistry” award / Dr. Andreas Walther (Aalto University, Helsinki, Finland) awarded prize in the “Materials” field (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4194031 Mon, 22 Nov 2010 10:00:00 +0100 4194031 http://www.medworm.com/index.php?rid=4194032&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com In both studies, all regimens of VEGF Trap-Eye, including VEGF Trap-Eye dosed every two months, achieved primary endpoint compared to ranibizumab dosed every month / Regulatory applications for marketing approval planned in first-half of 2011 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4194032 Mon, 22 Nov 2010 05:00:00 +0100 4194032 http://www.medworm.com/index.php?rid=4180821&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Major investment necessary in development pipeline, marketing and emerging markets / Annual savings of EUR 800 million planned from 2013 / Planned net reduction of about 2,000 jobs worldwide by the end of 2012 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4180821 Thu, 18 Nov 2010 17:15:00 +0100 4180821 http://www.medworm.com/index.php?rid=4173599&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Five new facilities to be completed by 2012 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4173599 Wed, 17 Nov 2010 10:30:00 +0100 4173599 http://www.medworm.com/index.php?rid=4165674&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com ROCKET AF shows superiority of once-daily rivaroxaban over warfarin in protecting AF patients from stroke and non-CNS systemic embolism / Rivaroxaban demonstrates comparable major and non-major clinically relevant bleeding, as well as significantly lower rates of intracranial hemorrhage vs. warfarin / ROCKET AF is the seventh Phase III clinical trial with rivaroxaban to show consistently improved outcomes for rivaroxaban compared to standard of care (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4165674 Mon, 15 Nov 2010 14:00:00 +0100 4165674 http://www.medworm.com/index.php?rid=4146691&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Focus on umbrella brand and product brands to create value / Independent brand presences of Bayer Schering Pharma* and other units to be discontinued (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4146691 Mon, 08 Nov 2010 09:45:00 +0100 4146691 http://www.medworm.com/index.php?rid=4146692&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4146692 Mon, 08 Nov 2010 09:30:00 +0100 4146692 http://www.medworm.com/index.php?rid=4129259&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Complementary portfolios with strong growth opportunities in combining both businesses / Creation of southern hemisphere hub to drive product innovation (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4129259 Wed, 03 Nov 2010 07:00:00 +0100 4129259 http://www.medworm.com/index.php?rid=4113253&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4113253 Fri, 29 Oct 2010 07:45:00 +0100 4113253 http://www.medworm.com/index.php?rid=4113254&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Sales grow by 16.1 percent to EUR 8,581 million / EBITDA before special items up 10.5 percent to EUR 1,656 million / Core earnings per share increase by 21.8 percent to EUR 0.95 / Provisions of EUR 436 million established for litigations / Net financial debt reduced by EUR 1.6 billion to EUR 9.1 billion / Group outlook for 2010 confirmed (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4113254 Thu, 28 Oct 2010 05:30:00 +0100 4113254 http://www.medworm.com/index.php?rid=4113255&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Unlocking new business potential with sustainable solutions (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4113255 Wed, 27 Oct 2010 08:00:00 +0100 4113255 http://www.medworm.com/index.php?rid=4102724&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com 3.2 million entries from 95 countries – a new record / Bayer, UNEP and other partners present prizes in Japan to children from all over the world / Motto of the next competition: “Life in the Forests” (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4102724 Sun, 24 Oct 2010 12:00:00 +0100 4102724 http://www.medworm.com/index.php?rid=4054555&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4054555 Mon, 11 Oct 2010 06:30:00 +0100 4054555 http://www.medworm.com/index.php?rid=4038696&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4038696 Thu, 07 Oct 2010 10:00:00 +0100 4038696 http://www.medworm.com/index.php?rid=4008293&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com First and only contraceptive to raise folate levels, reducing the risk of neural tube defects / First and only FDA-approved birth control pill with four indications (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=4008293 Mon, 27 Sep 2010 06:00:00 +0100 4008293 http://www.medworm.com/index.php?rid=3990526&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Establishment of Chief Operating Officer function to drive customer-based solutions across Crop Protection and BioScience segments / Strategic business development and management functions to be brought together in new area ‘Strategy & Business Management’ / Bayer CropScience CEO designate Sandra E. Peterson: “New alignment forms the management basis for further developing Bayer CropScience going forward” (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3990526 Wed, 22 Sep 2010 10:45:00 +0100 3990526 http://www.medworm.com/index.php?rid=3967406&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Towards faster and more efficient vegetable variety development (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3967406 Tue, 14 Sep 2010 11:00:00 +0100 3967406 http://www.medworm.com/index.php?rid=3949005&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Board Member Dr. Plischke: Proof of the success of our sustainability strategy / Index offers investors a basis for making sustainable investment decisions (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3949005 Thu, 09 Sep 2010 11:45:00 +0100 3949005 http://www.medworm.com/index.php?rid=3949006&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Friedrich Berschauer hands over reins to Sandra E. Peterson / New crop protection agents with peak sales potential of more than EUR 1 billion / BioScience Business Unit plans around 18 new products by 2016 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3949006 Thu, 09 Sep 2010 08:29:00 +0100 3949006 http://www.medworm.com/index.php?rid=3944639&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Three Bayer-research teams have been awarded for excellent innovations / Bayer: Record-budget for research and development with Euros 3,1 billion in 2010 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3944639 Wed, 08 Sep 2010 10:00:00 +0100 3944639 http://www.medworm.com/index.php?rid=3937610&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com New formulation expected to be launched in November 2010 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3937610 Mon, 06 Sep 2010 08:15:00 +0100 3937610 http://www.medworm.com/index.php?rid=3923140&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Global peak sales potential of about EUR 300 million (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3923140 Wed, 01 Sep 2010 12:30:00 +0100 3923140 http://www.medworm.com/index.php?rid=3918269&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Results from EINSTEIN-DVT Study Presented at European Society of Cardiology Congress 2010 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3918269 Tue, 31 Aug 2010 06:05:00 +0100 3918269 http://www.medworm.com/index.php?rid=3897896&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com The Company donates Cash and Medicines worth EUR 130,000 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3897896 Tue, 24 Aug 2010 09:45:00 +0100 3897896 http://www.medworm.com/index.php?rid=3819306&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Rivaroxaban shows superiority to standard therapy in net clinical benefit, a secondary endpoint of the study / Rivaroxaban well tolerated in this long-term trial / Full data set to be presented at Hot Line Session at ESC 2010 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3819306 Wed, 04 Aug 2010 15:51:00 +0100 3819306 http://www.medworm.com/index.php?rid=3819307&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3819307 Wed, 04 Aug 2010 12:00:00 +0100 3819307 http://www.medworm.com/index.php?rid=3797062&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Sales grow by 14.6 percent to EUR 9,179 million / EBITDA before special items up 8.6 percent to EUR 1,917 million / Core earnings per share increase by 9.5 percent to EUR 1.15 / Investing in the future: research and development expenses in 2010 to reach a new high of approximately EUR 3.1 billion / Group outlook confirmed for 2010 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3797062 Thu, 29 Jul 2010 05:30:00 +0100 3797062 http://www.medworm.com/index.php?rid=3756256&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Routine® already successfully launched in Korea (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3756256 Thu, 15 Jul 2010 09:45:00 +0100 3756256 http://www.medworm.com/index.php?rid=3682099&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Orodispersible formulation of Levitra® (vardenafil HCI) soon available (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3682099 Mon, 21 Jun 2010 07:00:00 +0100 3682099 http://www.medworm.com/index.php?rid=3669241&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Collaboration Focuses on the Discovery and Development of Multiple Antibody, Protein and Small Molecule Agents Targeting the Wnt Pathway (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3669241 Thu, 17 Jun 2010 08:00:00 +0100 3669241 http://www.medworm.com/index.php?rid=3664422&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Gianvi™’s label falsely claims that its formula and product, now in the US market, contains the same product stabilizer as YAZ® (drospirenone & ethinyl estradiol) Bayer’s oral contraceptive / Suit filed in the Northern District of Illinois (Chicago) (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3664422 Tue, 15 Jun 2010 18:00:00 +0100 3664422 http://www.medworm.com/index.php?rid=3657947&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Positive Secondary Endpoint of Progression Free Survival / Clinical Trial Program in Lung Cancer Ongoing (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3657947 Mon, 14 Jun 2010 06:30:00 +0100 3657947 http://www.medworm.com/index.php?rid=3650813&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Products, processes and applications for today and tomorrow (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3650813 Fri, 11 Jun 2010 07:59:00 +0100 3650813 http://www.medworm.com/index.php?rid=3634636&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Recognition of pioneering grief counseling for children and young people / “Ambulante Sozialpädagogik Charlottenburg” awarded second prize / Third prize for organ donation information project “Junge Helden” / Public choice award presented to “Deutscher Kinderhospizverein” (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3634636 Mon, 07 Jun 2010 10:30:00 +0100 3634636 http://www.medworm.com/index.php?rid=3616866&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Progress in projects focusing on health care, nutrition and climate protection / Highest reporting level “A+” achieved / Investing in the future: record R&D budget of EUR 2.9 billion / Goal reinforced: EUR 1 billion for climate protection / Corporate social responsibility: EUR 45 million for social projects / Diversity: 22 nations represented in top management / Bayer CEO Werner Wenning: “We are aiming for sustainability in everything we do” (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3616866 Tue, 01 Jun 2010 11:45:00 +0100 3616866 http://www.medworm.com/index.php?rid=3609090&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Employees and company donate EUR 350,000 / Bayer aid for Haiti including emergency measures totals more than EUR 1 million (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3609090 Fri, 28 May 2010 13:55:00 +0100 3609090 http://www.medworm.com/index.php?rid=3579725&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3579725 Thu, 20 May 2010 11:00:00 +0100 3579725 http://www.medworm.com/index.php?rid=3540709&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com The first and only contraceptive to bring estradiol valerate together with dienogest in a new dosing regimen / Product will be marketed as Natazia® in the U.S. (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3540709 Fri, 07 May 2010 11:00:00 +0100 3540709 http://www.medworm.com/index.php?rid=3517612&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com 2009 operationally a strong year in a difficult environment / Bayer stock performance in 2009: plus 40 percent / Proposal to pay an unchanged dividend of EUR 1.40 per share for 2009 / Strong gains in sales and earnings in the first quarter of 2010 / Personnel changes on the Board of Management and the Supervisory Board (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3517612 Fri, 30 Apr 2010 08:00:00 +0100 3517612 http://www.medworm.com/index.php?rid=3513582&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Sales advance by 5.3 percent to EUR 8,316 million / EBITDA before special items climbs by 13.2 percent to EUR 1,918 million / Net income up 63.1 percent to EUR 693 million / Core earnings per share increase by 31.9 percent to EUR 1.20 / Group outlook raised for 2010 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3513582 Thu, 29 Apr 2010 05:30:00 +0100 3513582 http://www.medworm.com/index.php?rid=3506629&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Current Chairman Prof. Friedrich Berschauer to retire / Achim Noack appointed to the Board of Management of Bayer CropScience / Dr. Dirk Van Meirvenne to be Managing Director of Bayer Technology Services (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3506629 Tue, 27 Apr 2010 12:15:00 +0100 3506629 http://www.medworm.com/index.php?rid=3496335&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Recognition of pioneering research into sea ice / Bayer Management Board Chairman Wenning: Scientifically grounded understanding of climate change necessary / Continue commitment to reducing global greenhouse emissions (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3496335 Thu, 22 Apr 2010 14:59:00 +0100 3496335 http://www.medworm.com/index.php?rid=3489047&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Arthur Higgins to leave the company at the end of April / Dr. Marijn Dekkers to head the subgroup temporarily as of May 1 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3489047 Wed, 21 Apr 2010 12:00:00 +0100 3489047 http://www.medworm.com/index.php?rid=3481944&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Company acted responsibly and appropriately at all times (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3481944 Mon, 19 Apr 2010 12:00:00 +0100 3481944 http://www.medworm.com/index.php?rid=3478693&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com More than 45 Country Affiliates Join the Global Hemophilia Community to Mark the Day with “Reach Out & Care” Theme (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3478693 Sat, 17 Apr 2010 12:00:00 +0100 3478693 http://www.medworm.com/index.php?rid=3418722&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Lower emissions through innovative oxygen depolarized cathode technology (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3418722 Tue, 30 Mar 2010 09:30:00 +0100 3418722 http://www.medworm.com/index.php?rid=3401552&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Changes in sea ice a barometer for climate change / Dr. Plischke, member of the Bayer Board of Management: Key principles for climate models and a decision-making basis for climate policy (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3401552 Thu, 25 Mar 2010 09:50:00 +0100 3401552 http://www.medworm.com/index.php?rid=3345056&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Enabling technology for the next generation of touchscreens (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3345056 Tue, 09 Mar 2010 08:45:00 +0100 3345056 http://www.medworm.com/index.php?rid=3333542&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com 100,000 Dollar Donation for Aid Campaign “Chile helps Chile” (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3333542 Fri, 05 Mar 2010 13:50:00 +0100 3333542 http://www.medworm.com/index.php?rid=3309587&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Group sales EUR 31,168 million (minus 5.3 percent) / EBITDA before special items EUR 6,472 million (minus 6.6 percent) / Net income EUR 1,359 million (minus 20.9 percent) / Net cash flow significantly improved to EUR 5,375 million (plus 49 percent) / Net financial debt reduced by EUR 4.5 billion to EUR 9.7 billion / Core earnings per share expected to improve by about 10 percent in 2010 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3309587 Fri, 26 Feb 2010 06:31:00 +0100 3309587 http://www.medworm.com/index.php?rid=3309588&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Reduction of short-term incentive and strengthening of long-term compensation component / Extended share retention period under long-term incentive program / Increased personal investment in Bayer stock / Adjustments effective January 1, 2010 / Compensation system to be submitted to Annual Stockholders’ Meeting for approval (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3309588 Fri, 26 Feb 2010 06:30:00 +0100 3309588 http://www.medworm.com/index.php?rid=3300371&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3300371 Wed, 24 Feb 2010 12:00:00 +0100 3300371 http://www.medworm.com/index.php?rid=3286061&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Ehrfeld Mikrotechnik BTS, a Bayer Technology Services company, to exclusively manufacture and market Lonza microreactors / Joint forces to develop green chemical syntheses (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3286061 Fri, 19 Feb 2010 06:30:00 +0100 3286061 http://www.medworm.com/index.php?rid=3281795&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Statistically significant improvement in vision achieved over 24 weeks / Results to be presented at the Angiogenesis 2010 – Clinical Trials meeting in Miami, Florida on February 20, 2010 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3281795 Thu, 18 Feb 2010 12:00:00 +0100 3281795 http://www.medworm.com/index.php?rid=3214746&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Idiotype vaccination in the treatment of non-Hodgkin’s lymphoma (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3214746 Thu, 28 Jan 2010 11:00:00 +0100 3214746 http://www.medworm.com/index.php?rid=3206974&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Bayer MaterialScience to implement EcoCommercial building program in Masdar City to highlight energy-efficient and economic construction in subtropical climate (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3206974 Tue, 26 Jan 2010 08:00:00 +0100 3206974 http://www.medworm.com/index.php?rid=3177790&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Medicines Donated as Immediate Relief (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3177790 Fri, 15 Jan 2010 17:00:00 +0100 3177790 http://www.medworm.com/index.php?rid=3073739&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Encouraging top-line data from the first Phase II study in pulmonary hypertension owing to interstitial lung disease (PH-ILD) / First Phase II study in pulmonary hypertension owing to chronic obstructive pulmonary disease (PH-COPD) successfully completed (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3073739 Thu, 10 Dec 2009 07:00:00 +0100 3073739 http://www.medworm.com/index.php?rid=3062380&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3062380 Mon, 07 Dec 2009 07:30:00 +0100 3062380 http://www.medworm.com/index.php?rid=3060697&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Discussions with FDA on Complete Response Letter for VTE Prevention After Total Knee and Hip Replacement Surgery (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3060697 Sun, 06 Dec 2009 13:59:00 +0100 3060697 http://www.medworm.com/index.php?rid=3050483&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com German Federal President Horst Köhler praises outstanding innovation achievement / Development of the novel oral anticoagulant rivaroxaban commended (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3050483 Wed, 02 Dec 2009 19:45:00 +0100 3050483 http://www.medworm.com/index.php?rid=3042455&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3042455 Tue, 01 Dec 2009 11:00:00 +0100 3042455 http://www.medworm.com/index.php?rid=3042456&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Launch planned by mid 2010 (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3042456 Tue, 01 Dec 2009 07:00:00 +0100 3042456 http://www.medworm.com/index.php?rid=3038230&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Detection of beta-Amyloid plaques in Alzheimer patients possible / Florbetaben could improve current diagnostic tools (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3038230 Mon, 30 Nov 2009 08:00:00 +0100 3038230 http://www.medworm.com/index.php?rid=3032499&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=3032499 Fri, 27 Nov 2009 10:00:00 +0100 3032499 http://www.medworm.com/index.php?rid=2979549&cid=s_34530_34_f&fid=34530&url=http%3A%2F%2Fwww.bayer.com Focus on the fields of health care, nutrition and climate protection / Eight lighthouse projects: More than 15 million people benefit directly / New technologies to reduce greenhouse gas emissions by five million metric tons per year / Management Board Chairman Wenning: “We are making specific contributions to balance commercial success with the protection of the environment and the needs of society” (Source: Bayer Company News) Bayer Company News news http://www.medworm.com/rss/comments.php?id=2979549 Wed, 11 Nov 2009 08:59:00 +0100 2979549